Sun Pharmaceutical Drug Mix-up Sparks Recall

By on March 19, 2014

Sun Pharmaceutical Industries Ltd., (SUNPHARMA.NS) recalled 2,528 bottles of Type 2 diabetes drug Metformin HCI after a consumer found tablets of the epilepsy drug Gabapentin in a Metformin HCI bottle. 

The recall was issued by Sun Pharmaceutical’s Detroit-based subsidiary Caraco Pharmaceutical Laboratories Ltd. and posted on the website of the U.S. Food and Drug Administration. 

U.S. regulators have been examining other pharmaceutical companies based in India including Ranbaxy Laboratories Ltd. for compliance with manufacturing standards. Ranbaxy issued its third recall of generic Lipitor. 

If you would like additional information on the Sun Pharmaceutical recall or other news, please click the green button below and fill out the form.